Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2009 026 481.8 |
96 | EP file number | EAKZ | 09 79 0935.2 |
86 | WO file number | WAKZ | PCT/US2009/052103 |
97 | EP publication number | EPN | 2318050 |
87 | WO publication number | WPN | 2010014708 |
54 | Designation/title | TI | FAKTOR-VIII-POLYMER-KONJUGATE |
51 | IPC main class | ICM (ICMV) | A61K 47/50 (2017.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07K 14/745 (2006.01) |
22 | DE application date | DAT | Jul 29, 2009 |
96 | EP application date | EAT | Jul 29, 2009 |
86 | WO application date | WAT | Jul 29, 2009 |
43 | Date of first publication | OT | Feb 4, 2010 |
| Date of publication of grant | PET | Sep 3, 2014 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP |
72 | Inventor | IN | SIEKMANN, Juergen, A-1210 Vienna, AT; TURECEK, Peter, A-3400 Klosterneuburg, AT |
74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 184567 Aug 1, 2008
|
| Due date | FT FG | Jul 31, 2026 Annual fee for the 18th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR |
81 | Designated WO countries | WDS | AL, RS, BA |
| Published EP/WO documents | EPWOPN | Original document:
EP000002318050 Searchable text:
EP000002318050 Original document:
EP000002318050B1 Searchable text:
EP000002318050B1 Original document:
WO002010014708 Searchable text:
WO002010014708 |
43 | Date of first publication | EVT | Feb 4, 2010 |
| Date of the first transfer into DPMAregister | EREGT | Jun 22, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 2, 2025 (Show all update days)(Hide all update days)- Jul 2, 2025
- Due date: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 03.09.2014: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 03.09.2014: deleted
- Aug 9, 2024
- St.36: changed (technical change)
- Jun 22, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Feb 16, 2016 |
| Issue number | HN | 12 |
| Year | PJ | 2016 |
| Publication date | VT | Mar 24, 2016 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Baxalta GmbH, Glattpark, Opfikon, CH; Baxalta Incorporated, Bannockburn, Ill., US |
71/73 | Previous applicant/owner | INHF | Baxter Healthcare S.A., Glattpark, CH, Baxter International Inc., Deerfield, Ill., US |
View procedures New applicant/owner details (No.: 13)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 4, 2021 |
| Issue number | HN | 28 |
| Year | PJ | 2021 |
| Publication date | VT | Jul 15, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Co. Ltd., Osaka, JP |
71/73 | Previous applicant/owner | INHF | Baxalta GmbH, Glattpark, Opfikon, CH, Baxalta Incorporated, Bannockburn, Ill., US |
| Date of update of the procedure | REGT | Jun 29, 2021 |